Pioneers in immunometabolism
We’re altering immune cell metabolism to resolve disease
The field of immunometabolism is an exciting area of medicine investigating the role of intracellular metabolic pathways in immune cells.
Metabolic pathways play a central role in regulating immune cell function and activation, with dysregulation across these pathways impacting immune response and contributing to the progression of chronic autoimmune and inflammatory disease.
Immunometabolic therapies offer complementary and highly differentiated approaches to treating disease by correcting immune cell function.
We are building a broad pipeline of first- and best-in-class therapies with the potential to rebalance the immune system and achieve disease remission, leading to better patient outcomes.
Outstanding Foundations
Globally renowned scientific founders and a highly experienced team
Cutting Edge Science
Exploiting the intersection of immune system function and metabolism
Industry Validation
A collaboration with Eli Lilly worth up to $1.1 billion in potential development and commercial milestones in addition to tiered royalties
Transformational Therapeutics
Building a broad pipeline of first- and best-in-class disease-modifying therapies with the potential to achieve disease remission
Shifting the balance to treat disease
An imbalance of the immune system exists in autoimmune and inflammatory disease.
Metabolic pathways drive the functional identity of cells of the immune system.
The balance of the system can be impacted by modulating the metabolism of immune cells and vice versa.